Trial NCT01379469

View at ClinicalTrials.gov 
Org. Study IDs: 201510060-PRO09070279
Secondary IDs: 1R21DK092567-01

Last trial update was posted on 2021-10-12

MeSH Interventions

Carbamazepine

MeSH Conditions

Alpha 1-Antitrypsin Deficiency Liver Cirrhosis Liver Diseases

Other Conditions

Alpha-1-antitrypsin Deficiency

Stopping Reasons

N/A

Limitations And Caveats

The primary & secondary outcomes could not be assessed because the number of subjects with available pre & post biopsies was insufficient in subject number and sample quality to conduct the analyses. As described in more detail in Outcome Measures. .

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID